Where Americans earn the most from investments
Where Americans earn the most from investments
Net capital gains, the profits from selling assets like stocks, real estate, or businesses, are a key measure of investment success and regional wealth. These gains are realized only upon sale and are taxable at preferential rates when held for a year or longer: 0%, 15% or 20%. Other investment incomes, such as ordinary dividends and taxable interest, which are taxed at generally higher income tax rates, or tax-exempt interest (often from municipal bonds), may offer other advantages for a diversified portfolio or retirement account withdrawal strategies. Overall, high net capital gains can signal robust markets and affluent populations, with realized gains potentially boosting local economies through tax revenues and spending.
With this in mind, SmartAsset ranked U.S. counties and states by the average net capital gains reported on the latest tax return data per the IRS. Other types of investment gains were also considered.
Key findings
Teton County, Wyoming investment gains lead all counties by wide margin. Teton County reported the highest average net capital gain per return at $515,267, far surpassing other counties. With a relatively small number of returns (6,010 reporting gains out of 15,180 total), this affluent area also showed significant ordinary dividends ($196,121 average 6,150 returns) and qualified dividends ($167,921 average on 5,940 returns), signaling a concentration of high-net-worth individuals and diversified investment activity.Florida ekes past Wyoming for highest state-level investment gains. Florida topped the state rankings with an average net capital gain per return of $84,911. The state's 2,136,380 returns reporting gains amounted to $181.4 billion, bolstered by high activity in counties like Palm Beach ($40.4 billion in gains) and Miami-Dade ($37.4 billion). Wyoming comes in a close second place for average net capital gains of $84,246 across nearly 60,000 tax returns.These Georgia counties report the lowest capital gains. At the opposite end, Chattahoochee, Quitman and Taliaferro counties in Georgia have the lowest net capital gains in the contiguous states with an average of $2,400 or less each. Few returns reported net capital gains at all, as they were reported on less than 10% of tax returns across these counties.West Virginia lags in state-level investment returns. West Virginia reported the lowest average net capital gain per return at $14,612, with only 91,930 returns reporting $1.34 billion in gains. Wisconsin has the second lowest average net capital gains reported at $19,590.
Top 20 counties where Americans made the most in investments
Counties are ranked based on the average net capital gains for applicable tax returns according to the latest IRS data.
Teton County, Wyoming
Avg. net capital gains: $515,267 (6,010 returns)Avg. taxable interest: $40,033 (7,100 returns)Avg. tax-exempt interest: $39,659 (2,020 returns)Avg. ordinary dividends: $196,121 (6,150 returns)Avg. qualified dividends: $167,921 (5,940 returns)Total returns: 15,180
Clinch County, Georgia
Avg. net capital gains: $317,793 (150)Avg. taxable interest: $977 (430)Avg. tax-exempt interest: $1,600 (20)Avg. ordinary dividends: $6,336 (110)Avg. qualified dividends: $4,055 (110)Total returns: 2,390
Pitkin County, Colorado
Avg. net capital gains: $312,592 (4,170)Avg. taxable interest: $30,111 (4,600)Avg. tax-exempt interest: $28,688 (1,280)Avg. ordinary dividends: $67,047 (4,280)Avg. qualified dividends: $53,044 (4,080)Total returns: 10,480
Shackelford County, Texas
Avg. net capital gains: $233,680 (300)Avg. taxable interest: $6,082 (510)Avg. tax-exempt interest: $13,317 (120)Avg. ordinary dividends: $16,190 (300)Avg. qualified dividends: $11,627 (300)Total returns: 1,480
Summit County, Utah
Avg. net capital gains: $219,262 (9,370)Avg. taxable interest: $9,425 (11,110)Avg. tax-exempt interest: $22,022 (2,870)Avg. ordinary dividends: $47,348 (9,530)Avg. qualified dividends: $36,713 (9,050)Total returns: 24,870
Monroe County, Florida
Avg. net capital gains: $191,886 (12,220)Avg. taxable interest: $13,432 (15,760)Avg. tax-exempt interest: $29,645 (3,310)Avg. ordinary dividends: $75,201 (11,770)Avg. qualified dividends: $66,673 (10,980)Total returns: 45,760
Palm Beach County, Florida
Avg. net capital gains: $186,281 (216,920)Avg. taxable interest: $16,155 (249,310)Avg. tax-exempt interest: $29,882 (63,780)Avg. ordinary dividends: $50,783 (220,150)Avg. qualified dividends: $42,043 (205,200)Total returns: 784,220
Miami-Dade County
Avg. net capital gains: $184,899 (202,220)Avg. taxable interest: $13,127 (261,490)Avg. tax-exempt interest: $23,350 (33,130)Avg. ordinary dividends: $38,036 (177,420)Avg. qualified dividends: $29,924 (160,110)Total returns: 1,436,490
Collier County, Florida
Avg. net capital gains: $184,017 (73,450)Avg. taxable interest: $12,151 (88,560)Avg. tax-exempt interest: $29,690 (26,040)Avg. ordinary dividends: $57,951 (74,510)Avg. qualified dividends: $47,507 (70,210)Total returns: 213,630
San Miguel County, Colorado
Avg. net capital gains: $183,621 (1,560)Avg. taxable interest: $9,440 (1,850)Avg. tax-exempt interest: $17,268 (470)Avg. ordinary dividends: $37,121 (1,560)Avg. qualified dividends: $25,636 (1,490)Total returns: 4,500
Blaine County, Idaho
Avg. net capital gains: $176,812 (4,910 returns)Avg. taxable interest: $10,555 (5,970 returns)Avg. tax-exempt interest: $19,372 (1,610 returns)Avg. ordinary dividends: $48,990 (5,020 returns)Avg. qualified dividends: $38,999 (4,790 returns)Total returns: 13,540
Randolph County, Missouri
Avg. net capital gains: $150,127 (1,720)Avg. taxable interest: $1,262 (2,930)Avg. tax-exempt interest: $4,845 (310)Avg. ordinary dividends: $5,540 (1,720)Avg. qualified dividends: $3,916 (1,620)Total returns: 10,580
New York County, New York
Avg. net capital gains: $149,273 (302,610)Avg. taxable interest: $19,397 (349,610)Avg. tax-exempt interest: $18,965 (99,390)Avg. ordinary dividends: $42,540 (334,330)Avg. qualified dividends: $32,211 (320,550)Total returns: 846,440
Walton County, Florida
Avg. net capital gains: $140,537 (10,470)Avg. taxable interest: $8,426 (14,280)Avg. tax-exempt interest: $17,430 (2,510)Avg. ordinary dividends: $27,814 (9,870)Avg. qualified dividends: $21,624 (9,210)Total returns: 40,310
Martin County, Florida
Avg. net capital gains: $130,146 (28,290)Avg. taxable interest: $10,613 (33,350)Avg. tax-exempt interest: $19,398 (8,070)Avg. ordinary dividends: $39,381 (29,640)Avg. qualified dividends: $32,712 (27,770)Total returns: 84,420
Indian River County, Florida
Avg. net capital gains: $126,594 (25,510)Avg. taxable interest: $9,009 (32,130)Avg. tax-exempt interest: $23,468 (7,530)Avg. ordinary dividends: $42,487 (27,010)Avg. qualified dividends: $35,483 (25,230)Total returns: 85,800
Wasatch County, Utah
Avg. net capital gains: $113,429 (4,520)Avg. taxable interest: $5,083 (6,350)Avg. tax-exempt interest: $10,513 (1,030)Avg. ordinary dividends: $17,528 (4,290)Avg. qualified dividends: $13,262 (3,950)Total returns: 16,800
Nemaha County, Kansas
Avg. net capital gains: $111,880 (1,480)Avg. taxable interest: $1,936 (2,700)Avg. tax-exempt interest: $10,200 (290)Avg. ordinary dividends: $18,627 (1,260)Avg. qualified dividends: $17,662 (1,180)Total returns: 4,920
Dallas County, Texas
Avg. net capital gains: $110,534 (188,570)Avg. taxable interest: $7,393 (243,770)Avg. tax-exempt interest: $14,890 (43,870)Avg. ordinary dividends: $24,441 (192,290)Avg. qualified dividends: $20,200 (179,610)Total returns: 1,213,090
Travis County, Texas
Avg. net capital gains: $109,439 (172,730)Avg. taxable interest: $5,131 (206,890)Avg. tax-exempt interest: $9,958 (40,820)Avg. ordinary dividends: $16,792 (178,910)Avg. qualified dividends: $12,869 (169,300)Total returns: 636,070
Top 10 states where Americans made the most in investments
States and the District of Columbia are ranked based on the average net capital gains for applicable tax returns according to the latest IRS data.
Florida
Avg. net capital gains: $84,911 (2,136,380 returns)Avg. taxable interest: $5,552 (2,956,740 returns)Avg. tax-exempt interest: $15,226 (472,050 returns)Avg. ordinary dividends: $21,724 (2,201,800 returns)Avg. qualified dividends: $17,828 (36,100,028 returns)Total returns: 11,050,580
Wyoming
Avg. net capital gains: $84,246 (59,890)Avg. taxable interest: $4,804 (100,040)Avg. tax-exempt interest: $12,016 (14,120)Avg. ordinary dividends: $30,728 (60,010)Avg. qualified dividends: $26,119 (1,466,868)Total returns: 279,330
Nevada
Avg. net capital gains: $77,491 (251,070)Avg. taxable interest: $4,395 (375,360)Avg. tax-exempt interest: $12,978 (47,730)Avg. ordinary dividends: $17,308 (239,070)Avg. qualified dividends: $13,756 (3,032,876)Total returns: 1,541,730
District of Columbia
Avg. net capital gains: $58,733 (86,250)Avg. taxable interest: $3,284 (114,880)Avg. tax-exempt interest: $7,804 (23,820)Avg. ordinary dividends: $15,743 (99,870)Avg. qualified dividends: $12,546 (1,196,872)Total returns: 346,460
Texas
Avg. net capital gains: $52,926 (2,151,560)Avg. taxable interest: $3,231 (3,239,600)Avg. tax-exempt interest: $9,046 (462,640)Avg. ordinary dividends: $13,420 (2,195,330)Avg. qualified dividends: $10,928 (22,353,519)Total returns: 13,542,000
Utah
Avg. net capital gains: $51,745 (262,790)Avg. taxable interest: $2,725 (439,680)Avg. tax-exempt interest: $7,213 (45,330)Avg. ordinary dividends: $10,015 (258,460)Avg. qualified dividends: $7,776 (1,852,455)Total returns: 1,506,540
Connecticut
Avg. net capital gains: $49,914 (425,050)Avg. taxable interest: $4,568 (616,860)Avg. tax-exempt interest: $9,708 (104,560)Avg. ordinary dividends: $18,385 (484,440)Avg. qualified dividends: $15,312 (7,025,689)Total returns: 1,812,680
New York
Avg. net capital gains: $48,271 (2,015,350)Avg. taxable interest: $4,110 (3,530,740)Avg. tax-exempt interest: $10,084 (507,120)Avg. ordinary dividends: $14,987 (2,224,750)Avg. qualified dividends: $11,626 (24,429,547)Total returns: 9,690,950
Massachusetts
Avg. net capital gains: $47,346 (834,390)Avg. taxable interest: $2,485 (1,403,790)Avg. tax-exempt interest: $7,575 (215,670)Avg. ordinary dividends: $13,507 (946,230)Avg. qualified dividends: $10,726 (9,551,537)Total returns: 3,550,000
California
Avg. net capital gains: $45,490 (3,852,310)Avg. taxable interest: $2,537 (6,852,810)Avg. tax-exempt interest: $9,879 (866,810)Avg. ordinary dividends: $13,724 (3,899,070)Avg. qualified dividends: $10,751 (39,305,988)Total returns: 18,355,830
Data and methodology
Data in this SmartAsset study is from the latest tax return release (2022 tax year) from the Internal Revenue Service (IRS). The rankings include 3,022 U.S. counties, as well as a separate ranking for the 50 states and the District of Columbia, based on the average net capital gains reported for applicable returns. Line-items for other investment gains, such as taxable interest, ordinary dividends and qualified dividends are also reported.
This story was produced by SmartAsset and reviewed and distributed by Stacker.
© Stacker Media, LLC.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
18 minutes ago
- Miami Herald
RFK Jr. plans crackdown on pharma ads in threat to $10 billion market
The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending. Although the U.S. is the only place, besides New Zealand, where pharma companies can directly advertise, banning pharma ads outright could make the administration vulnerable to lawsuits, so it's instead focusing on cutting down on the practice by adding legal and financial hurdles, according to people familiar with the plans who weren't authorized to speak publicly on the matter. The two policies the administration has focused in on would be to require greater disclosures of side effects of a drug within each ad - likely making broadcast ads much longer and prohibitively expensive - or removing the industry's ability to deduct direct-to-consumer advertising as a business expense for tax purposes, these people said. The discussions are ongoing and plans could still change before the agency undertakes any action, they said. Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He's long wanted to more strictly regulate how medicines are promoted. He's said he believes Americans consume more drugs than people in other countries because of the U.S. drug companies' ability to directly advertise to consumers. The new policies could threaten a key source of revenue to advertising and media companies, as well as the U.S. pharmaceutical industry. Companies spent $10.8 billion in 2024 on direct-to-consumer pharmaceutical advertising in total, according to a report from the advertising data firm MediaRadar. AbbVie Inc. and Pfizer Inc. were particularly big spenders. AbbVie alone spent $2 billion on direct-to-consumer drug ads last year, primarily on advertising for the company's anti-inflammatory drugs Skyrizi and Rinvoq. The medicines brought in more than $5 billion for AbbVie in the first quarter of 2025. "We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers," HHS spokesperson Andrew Nixon said in a written statement, adding that no final decisions have been made. AbbVie shares fell as much as 2.3% on Tuesday, their biggest drop in a month. Pfizer shares slipped as much as 1.7%. Ad reversal Before the loosening of advertising regulations by the Food and Drug Administration in 1997, U.S. pharma companies had to list all possible side effects for a medication if they wanted to mention which condition the drug being advertised was intended to treat. Reading out a list of side effects took so long it drove up the cost for air time and meant there wasn't as much broadcast advertising as there is today, said Jim Potter, executive director of the Coalition for Healthcare Communication, a trade association. The FDA change allowed ads to disclose fewer side effects and also allowed companies to direct customers to talk to their doctors, call a telephone number, or visit a website to get more information on the advertised drugs. In the following years, TV pharma ad spending surged. In 2024, 59% of the pharmaceutical industry's spend was on television advertising, making pharma the third-highest spending industry on television ads, according to MediaRadar. If the Trump administration brings back some of those restrictions, broadcast ads may become more "impractical," according to Meredith Rosenthal, a professor of health economics and policy at Harvard University's school of public health, who has studied the impacts of pharma advertising. More specific drug ads could have benefits for patients who might be prompted to talk to their doctor for the first time about a medical condition like depression or erectile dysfunction, Rosenthal said. However, there are also drawbacks. Drug ads can be used to drive sales of expensive, brand-name medicines when lower-cost generic alternatives may be appropriate, she said. When asked if a crackdown on ads would hurt its business, AbbVie chief commercial officer Jeff Stewart told analysts at a conference in May that the company "would have to pivot." He said the company could shift its investment to "disease awareness" or through advertising on digital channels rather than through mass media. Tax changes The Trump administration could also work with Congress to prohibit pharmaceutical companies from deducting direct-to-consumer advertising costs as business expenses on their taxes. House lawmakers discussed the idea in talks over President Donald Trump's tax cut legislation, but ultimately left the measure out of the bill. The Senate omitted it as well. HHS has been supportive of those discussions, according to a person familiar with the talks. Kennedy has also said publicly he's having conversations about tax changes within the administration, telling Senator Josh Hawley during a May hearing on Capitol Hill that he expected an announcement on the matter "within the next few weeks." Joe Grogan, who served as White House Domestic Policy Council chief during President Donald Trump's first term and now consults for health-care companies, said it's unclear whether lawmakers will have an appetite to crack down on the pharmaceutical industry further given Trump's tariff threats and demands to dramatically lower drug prices. Meanwhile, the pharmaceutical industry has warned that allowing lawmakers to regulate advertising by changing the tax code to single out pharmaceutical companies could set a dangerous precedent and raise the specter of lawsuits. Other industries also can deduct advertising costs as business expenses, heightening concerns they could be targeted next. "If you choose a sector, if one becomes a target, everyone becomes a target," said Potter of the Coalition for Healthcare Communication. The National Association of Broadcasters, which represents companies that own radio and television stations, said the group opposes restrictions on direct-to-consumer advertising, and that revenue from ads allows local broadcasters to staff newsrooms and invest in weather technology. "Restricting pharmaceutical ads would have serious consequences for stations, particularly those in smaller markets, and could raise First Amendment concerns," NAB spokesperson Alex Siciliano said. (With assistance from Madison Muller.) Copyright (C) 2025, Tribune Content Agency, LLC. Portions copyrighted by the respective providers.
Miami Herald
19 minutes ago
- Miami Herald
Walmart makes bold move to help inflation-battered consumers
If the economic data you keep reading in the news doesn't seem to align with your spending experience, you're not alone. Inflation is cooling – or at least that's what we're all being told. But let's be honest. Your last few grocery bills probably made you want to cry or punch a wall. Don't miss the move: Subscribe to TheStreet's free daily newsletter Although inflation hasn't been as rampant this year as in recent years, it's still very much a problem. Related: Growing supermarket chain makes bold move amid tariffs Many of us are paying through the roof to rent an apartment, put food on the table, and make sure we have basic necessities like water, electricity - and yes, a modest amount of entertainment. So even though economists may be able to point to cooling inflation on paper, that's not the typical American's reality right now. And things could unfortunately get worse before they get better. Image source: Jeff Greenberg/Getty Food is something we can't do without. Granted, we can choose where to buy our food if the goal is to save money. It's far cheaper to buy food at a supermarket, for example, than to buy it from a restaurant. Even within the realm of supermarkets, there are some that are known to offer better prices than others. Related: Walmart makes key move to help 'older' Americans But for the most part, we all have our staple grocery items we can't do without. And when the cost of those items increases, we tend to have no choice but to pay up. Making matters worse, looming tariffs could drive food costs up even further once the current pause comes to an end. Many retailers have already issued warnings stating they may have to raise prices once tariffs kick in. That could push cash-strapped consumers over the edge. At a time when so many retailers are raising prices on groceries, Walmart is offering an almost unbeatable deal right in time for summer. Now through July 6, Walmart is offering a 17-item cookout bundle at an almost unbelievable price. Related: Costco brings back huge perk members have missed The bundle, which is intentionally being released to coincide with the July 4th holiday, includes fresh products like hot dogs, burgers, lettuce, tomatoes, and corn. It also includes barbecue staples like buns, pickles, chips, baked beans, soda, and ice cream sandwiches for dessert. All told, the meal package is designed to leave up to eight people feeling nice and stuffed for under $6 per person. The July 4th bundle isn't the first time Walmart has made a budget-friendly meal package available to shoppers. In the past, Walmart has sold an Easter meal deal as well as an affordable Thanksgiving feast. Like many of its competitors, Walmart has warned that it won't be immune to the impact of tariffs. It recently said point blank that it may have to raise prices if it can't absorb the cost increases tariffs bring about on its own. For now, though, Walmart is doing what it can to offer consumers some amount of relief. Walmart has also, despite its warning, pledged to do its part to shield consumers from tariffs. Part of that strategy includes sourcing more of its goods domestically – a practice the retail giant already upholds. Walmart is also expanding its small business outreach program to help more local businesses become trusted suppliers. More retail: Walmart CEO sounds alarm on a big problem for customersTarget makes a change that might scare Walmart, CostcoTop investor takes firm stance on troubled retail brandWalmart and Costco making major change affecting all customers Called Grow with US, the program could be instrumental in creating more jobs and opening up more doors for smaller operations. And if it works the way it's supposed to, it could result in more locally produced goods that result in major cost savings for consumers. Related: Walmart makes surprise cuts as it looks at tariff price hikes The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Miami Herald
20 minutes ago
- Miami Herald
EVs suffer surprising rejection in a crucial market
Despite over a decade of government subsidies, electric vehicles still haven't taken off in the U.S. Undoubtedly, the segment has grown, due mainly to the popularity of Tesla (TSLA) , but the big automakers are still losing a lot of money on their electric vehicles. Ford, for example, has sold 6.1% more vehicles year to date than it did a year ago. However, the company did this despite selling 25% fewer EVs month to month, accelerating a declining sales trend for a segment of the company's brand that had been experiencing growth. Related: Jaguar Land Rover has big, growing problem on its hands Ford announced last year that its EV division would lose about $5 billion in 2024. The $1.5 billion the unit lost in the third quarter alone was actually an 8% improvement year over year. Meanwhile, back in 2023, General Motors said that despite losing money on EVs, it expected its EV segment to be profitable by this year. So far this year, GM's EV segment has been performing well, with sales more than doubling through the first five months of the year. The company sold 62,830 EVs through May, with Chevrolet driving 37,620 of those sales. This year, Chevy's performance alone has outstripped rival Ford, which has sold 34,132 vehicles across its all-electric lineup. However, the U.S. is only one of three major EV markets in the world. Europe and China have a much larger appetite for electric vehicles, but new data suggests one of those markets is also starting to slow down. Image source: Pool/Getty Images Americans bought 1.5 million EVs in 2023, while the Chinese bought 8.2 million. According to the International Energy Agency, European consumers purchased 3.2 million during the same period. However, a new study by the oil company Shell suggests that consumer sentiment is trending in the wrong direction in Europe. The 2025 Shell Recharge Driver Survey features responses from over 15,000 European drivers. The appetite to buy an EV among internal combustion engine (ICE) car drivers dropped to 41% from 48% last year. Related: Toyota makes surprising move to beat Tesla in key market While the sentiment also fell in the U.S., the 34% to 31% decline was less dramatic. The biggest issue for European drivers is the cost of the vehicles, as 43% of drivers cited affordability as their top issue. Despite falling battery costs, European EV prices have stagnated in recent quarters. A strong plurality on both sides of the pond believes ICE vehicles should be phased out completely. About 46% of ICE vehicle drivers in the U.S. agree with government policies encouraging the phasing out of ICE vehicles, while 44% of European ICE drivers feel that way. "This research reinforces what we hear from our customers: there's a growing disparity in the transition to electric vehicles," said Shell VP of Mobility and Convenience David Bunch. "While current EV drivers are feeling more confident, the relatively high cost of owning an electric vehicle, combined with broader economic pressures, are making it a difficult decision for new consumers." President Joe Biden and his Democrat predecessor saw climate change as an existential crisis and electric vehicles as a key to combating that crisis. Obama initiated the $7,500 EV tax rebate during his term, and Biden expanded the program during his. While it hasn't been a big subject for Trump this time around, he did call some of the rhetoric around climate change a hoax when he first ran for president back in 2015. EVs just aren't as popular in the U.S. as they are in China and Europe. However, hybrid vehicles, which are mainly ICE engines with a small battery backup, are gaining in popularity. Ford hybrid sales increased nearly 30% to 22,719 vehicles in May. Year to date, hybrid sales are up more than 31%. According to Bunch, hybrids could play a key role in ultimately decarbonizing our driving experiences. "With the right policies and industry collaboration, we can make the transition affordable for consumers and attractive for investors. But more must be done to stimulate demand and ensure no one is left behind in the shift to cleaner transport," he said. Related: 10,000 people join crazy Tesla class action lawsuit The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
